CD44 and neoplasm: Nonetheless, CD44+ CD8 T cells were found in MOC1 tumor tissues one week after combination of CD44-targeted NIR-PIT and CTLA4 mAb (Supplementary Figure S2), which suggested that newly induced T cells were accommodated and operated anti-tumor immune activity to suppress tumor growth for MOC1 tumors.